MTOR and renal cell carcinoma: The latter two tumors exhibit several overlapping features: the presence of eosinophilic cells, indolent behavior, and distinct molecular alterations, such as inactivating somatic mutations of the TSC2 gene or activating mutations of mTOR, as seen in ESC-RCC [31,32].